Document Detail


Central nervous system manifestations in VHL: genetics, pathology and clinical phenotypic features.
MedLine Citation:
PMID:  15883708     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
This review focuses on CNS hemangioblastomas in von Hippel-Lindau (VHL) disease. The pathogenesis of these lesions remains unclear to date; however, biallelic inactivation of the VHL tumor suppressor gene is thought to be an important step. These benign tumors occur frequently in patients with VHL disease and produce symptoms by mass effect either by the tumor itself or an accompanying cyst or edema. Furthermore, cases of spontaneous hemorrhage have been described. Genetic testing for VHL germline mutations is recommended in all patients with hemangioblastoma and yearly screening, including MRI of the brain and spine, is recommended for all VHL disease patients. Treatment of these tumors is mainly surgical. In general, surgery is indicated in symptomatic hemangioblastomas and eventually also in asymptomatic tumors that exhibit radiographic progression. However, since most VHL disease patients harbor multiple lesions, a careful individual decision must be made in each case. The tumors can usually be completely removed by dissection in the plane between tumor and CNS tissue and coagulating and cutting of the numerous feeding vessels with low power. As long as consequent yearly surveillance is performed and lesions are adequately treated in time, the prognosis of CNS hemangioblastomas in VHL disease is good. Preoperative neurological deficit, however, will not improve after surgery in most patients. Local tumor recurrences are rare.
Authors:
Sven Gläsker
Related Documents :
24533918 - Staging accuracy of ampullary tumors by endoscopic ultrasound: meta-analysis and system...
18332868 - Vprbp targets merlin to the roc1-cul4a-ddb1 e3 ligase complex for degradation.
17339318 - Interaction of hydroxylated collagen iv with the von hippel-lindau tumor suppressor.
18342578 - The tumor suppressors brat and numb regulate transit-amplifying neuroblast lineages in ...
16377078 - Establishment of a highly tumorigenic lncap cell line having inflammatory cytokine resi...
25289168 - Gamma knife radiosurgery for intracranial meningiomas: do we need to treat the dural ta...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Familial cancer     Volume:  4     ISSN:  1389-9600     ISO Abbreviation:  Fam. Cancer     Publication Date:  2005  
Date Detail:
Created Date:  2005-05-10     Completed Date:  2005-09-13     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  100898211     Medline TA:  Fam Cancer     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  37-42     Citation Subset:  IM    
Affiliation:
Department of Neurosurgery, Albert-Ludwigs-University, 79106 Freiburg, Germany. glaesker@nz.ukl.uni-freiburg.de
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Central Nervous System Neoplasms / etiology*,  genetics*,  physiopathology,  surgery
Disease Progression
Hemangioblastoma / etiology*,  genetics*,  physiopathology,  surgery
Humans
Phenotype
Prognosis
von Hippel-Lindau Disease / complications*,  genetics*,  physiopathology

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Multiple endocrine neoplasia type 2.
Next Document:  Ophthalmological manifestations in VHL and NF 1: pathological and diagnostic implications.